'Dna vaccine' diaporamas de présentation

Challenges of a Zika virus vaccine development

2.13k views • 135 slides

Types of Vaccines and Patentability Considerations

United States Patent and Trademark Office. Types of Vaccines and Patentability Considerations. Christina Chan Supervisory Primary Examiner Art Unit 1644 Phone: 571-272-0841 E-mail: christina.chan@uspto.gov. Acquisition Of Passive And Active Immunity. Type Acquired through

561 views • 41 slides

Development of HIV vaccine in Russia

Development of HIV vaccine in Russia. A.P.Kozlov The Biomedical Center, Research Institute of Pure Biochemicals and St.Petersburg University St. Petersburg, Russia. The History of Russian HIV Vaccine Project.

584 views • 37 slides

Gene vaccine

468 views • 34 slides

NEERAJ KUMAR ,AVTAR , (students) JITENDER MEHLA (Research Scholar) ,NDRI

DNA VACCINES. NEERAJ KUMAR ,AVTAR , (students) JITENDER MEHLA (Research Scholar) ,NDRI and Dr. S.K. Sood , Senior scientist,NDRI,Karnal. Introduction History DNA vaccines Vs Traditional vaccines How DNA vaccine is made Methods of delivery How DNA vaccine works.

319 views • 31 slides

284 views • 28 slides

91390585-- ?????????? -- ???

Coimmunization of Agaricus blazei Murill extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune responses.

424 views • 25 slides

372 views • 22 slides

Progress and perspectives for DNA vaccines in Russia

Progress and perspectives for DNA vaccines in Russia B. Murashev, O. Nazarenko, E. Akulova, S. Verevochkin, M. Astanina, T. Krasnoselskih, D. Leoznov, E. Sokolovskiy, A. Kozlov. HIV-1 genome ( consensus sequence of the FSU subtype A HIV-1 variant ). GAG. POL. ENV. NEF. LTR. LTR.

311 views • 19 slides

Towards An HIV-1 Vaccine

342 views • 19 slides

INFLUENZA A periodic global threat

INFLUENZA A periodic global threat. Influenza vaccine. MMWR 2003; 52:987-92 INFLUENZA: the leading cause of vaccine-preventable deaths in the United States. Influenza vaccine. Four generations Killed vaccine - past (present) Split vaccine - present (future)

242 views • 11 slides

Case Study West Nile Virus (WNV)

Case Study West Nile Virus (WNV). In 2001 , CDC published an article in the Journal of Virology showing that a single dose of a DNA vaccine could prevent WNV infection in mice and horses. Case Study WNV Paper Metrics. Case Study West Nile Virus (WNV).

329 views • 7 slides

DNA Vaccines Market by Method, Application and Segment to 2014-2025

The key driving factors responsible for the growth of DNA Vaccines Market include growing vulnerability of population to infectious disease and rising number of antibiotics resistant pathogens have generated the need for effective and low cost vaccination which would provide lasting immunity.

47 views • 3 slides

DNA Vaccine Market Growth Factors, End User Analysis and Forecast to 2022

The Global DNA Vaccine Market size is expected to display higher growth rate over the next seven years. The market is subject to witness a substantial growth due to the high-end demand for effective and low cost vaccines. Growing prevalence of infectious diseases, ever-increasing geriatric population, rising vulnerability towards genetic diseases and rising number of resistant pathogens are expected to drive market demand for DNA vaccines in the upcoming years.

36 views • 3 slides